等待開盤 10-09 09:30:00 美东时间
0.000
0.00%
On September 30, 2025, INVO Fertility, Inc. (the "Company") finalized its settlement agreement with Dr. Elizabeth Pritts ("Dr. Pritts"), consistent with terms of the binding term sheet previously disclosed and filed as
10-04 04:20
(来源:美股情报站) 9月11日,艾伯维在股市上展现出强势表现,股价上涨4.05%,连续上涨三天,累计上涨4.97%。当天,艾伯维的股价达到盘中历史新高,充分...
09-12 06:32
AbbVie's settlement with generic rivals delays upadacitinib competition in the U.S. until at least 2037, supporting its long-term market presence.
09-11 21:55
An announcement from AbbVie ( ($ABBV) ) is now available. On September 11, 2025...
09-11 20:01
NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Fundstrat Capital announced that it has filed a preliminary prospectus with the U.S. Securities and Exchange Commission ("SEC") for two new exchange-t...
08-25 19:30
INVO Fertility shares are trading lower after the company reported a year-over-...
08-16 01:53
INVO Fertility ( ($IVF) ) has provided an update. On July 28, 2025, an institut...
08-02 04:53
转自:证券时报 人民财讯8月1日电,艾伯维近日宣布,upadacitinib(RINVOQ®)治疗斑秃的UP-AA临床研究中两项关键性研究中的第一项取得积极结果...
08-01 13:01